TLPH Debt / Equity | TALPHERA, INC.

TALPHERA, INC. (TLPH) Debt / Equity

2022-12-31: Debt/Equity Ratio 0.25.
2022-09-30: Debt/Equity Ratio 0.29.
2022-06-30: Debt/Equity Ratio 0.3.
2022-03-31: Debt/Equity Ratio -0.31.

Complete source-backed debt/equity ratio history.

Available history: 2011-09-30 to 2022-12-31
Data captured: 2026-09-04

Historical Debt/Equity Ratio

Date	Debt/Equity Ratio
2022-12-31	0.25
2022-09-30	0.29
2022-06-30	0.3
2022-03-31	-0.31
2021-12-31	-0.38
2021-09-30	-0.37
2021-06-30	-0.5
2021-03-31	-0.73
2020-12-31	-0.39
2020-09-30	-0.41
2020-06-30	-0.43
2020-03-31	-0.47
2019-12-31	-0.61
2019-09-30	-0.85
2018-12-31	2.82
2018-09-30	-0.37
2018-06-30	-0.32
2018-03-31	-0.37
2017-12-31	-0.52
2017-09-30	-0.74
2017-06-30	-0.7
2017-03-31	-1.1
2016-12-31	-4.04
2016-09-30	6.52
2016-06-30	1.58
2016-03-31	0.9
2015-12-31	0.63
2015-06-30	0.69
2015-03-31	0.61
2014-12-31	0.53
2014-09-30	0.42
2014-06-30	0.44
2013-09-30	0.2
2013-06-30	2.05
2013-03-31	0.65
2012-12-31	0.47
2012-09-30	-54.07
2012-06-30	2.53
2012-03-31	1.74
2011-12-31	1.09
2011-09-30	0.38

Annual Debt/Equity Ratio

Date	Debt/Equity Ratio
2022-12-31	0.25
2021-12-31	-0.38
2020-12-31	-0.39
2019-12-31	-0.61
2018-12-31	2.82
2017-12-31	-0.52
2016-12-31	-4.04
2015-12-31	0.63
2014-12-31	0.53
2012-12-31	0.47
2011-12-31	1.09

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
CalciMedica, Inc. (CALC)	United States	$0.061B	-1.42
Skye Bioscience, Inc. (SKYE)	United States	$0.061B	-0.48
Boundless Bio, Inc. (BOLD)	United States	$0.059B	-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)	United States	$0.058B
Rein Therapeutics, Inc. (RNTX)	United States	$0.063B	-1.76
Annovis Bio, Inc. (ANVS)	United States	$0.056B	-1.58
HYPERION DEFI, INC. (HYPD)	United States	$0.065B
XBiotech Inc. (XBIT)	United States	$0.066B	-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)	United States	$0.055B	-2.38
Clene Inc. (CLNN)	United States	$0.054B	-1.99